More dates

    HealthTech Hub Masterclass: What are the Fundamental Aspects of Business Communications for Health Innovators?

    This event has passed Get tickets

    Event description

    When you start a business, mastering the fundamentals of good business communication matters. As an early founder, you know it is important, but you may not yet know how to build a website, have a social media presence and manage the public persona of the company, team and founders. So where do you start? How can you be resourceful, strategic and agile?

    What You Will Learn:

    In this Masterclass, our communication experts take you through:

    • Why does communication matter?
    • Who should you be talking to?
    • What do they care about?
    • Where are they active online?
    • Where do they currently get industry information from?
    • When are they most likely open to new business / too busy?
    • How will people find you online?
    • How can you spread your profile/website online?


      Who Should Attend:

      This masterclass is designed for entrepreneurs, researchers, and professionals in the health tech sector who are looking for guidance on how to create or improve their business communications with key stakeholders, including customers, partners and investors.

        Meet the Experts:


          **Lunch will be provided

          Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.

          Find out more about the Cicada HealthTech Hub 


          The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.


            Powered by

            Tickets for good, not greed Humanitix donates 100% of profits from booking fees to charity